Showing results (251-260 of 332) with videos related to

Sort By:
Pageof 34
Blood|April 18, 2014
Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemiaKheira Beldjord, Sylvie Chevret, Vahid Asnafi, et al.
Bone Marrow Transplantation|October 19, 2022
Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TCPaul Chauvet, Annalisa Paviglianiti, Myriam Labopin, et al.
Bone Marrow Transplantation|December 20, 2017
Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMTGwendolyn van Gorkom, Michel van Gelder, Dirk-Jan Eikema, et al.
Transplantation and Cellular Therapy|June 10, 2026
Polyomavirus-Specific T Cells in Progressive Multifocal Leukoencephalopathy: A Multicenter Retrospective AnalysisAlexandre Chevalier, Baptiste Bonneau, Lea Grote-Levi, et al.
Current Research in Translational Medicine|September 13, 2018
Scoring System Based on Post-Transplant Complications in Patients after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Study from the SFGM-TCAlexis Caulier, Elodie Drumez, Jordan Gauthier, et al.
Blood|February 11, 2012
Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS studyBruno Lioure, Marie C Béné, Arnaud Pigneux, et al.
JAMA|August 9, 2017
Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical TrialAnne Bergeron, Sylvie Chevret, Angela Granata, et al.
Bone Marrow Transplantation|August 29, 2025
Conditioning intensity in myelodysplastic patients aged ≥ 50 years undergoing allogeneic hematopoietic cell transplantation (allo-HCT): a study on behalf of the chronic malignancies working party of the EBMTNoureddine Henoun Loukili, Luuk Gras, Linda Koster, et al.
The Lancet. Haematology|August 10, 2025
Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (GFM-DACORAL-DLI): a multicentre, single-arm, phase 2 trialMarie Robin, Maud D'Aveni, Aspasia Stamatoullas, et al.
Bone Marrow Transplantation|August 14, 2024
Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMTRazan Mohty, Abdul Hamid Bazarbachi, Myriam Labopin, et al.
Pageof 34